Blink Device Company Announces TwitchView™ Quantitative Monitor for

Neuromuscular Blockade is Now Compatible with Major Electronic Medical

Records

Seattle, WA, June 04, 2019 --(PR.com)-- Blink Device Company announced today that the
TwitchView™ quantitative train-of-four (TOF) monitor now integrates with most major electronic
medical records (EMR). Commercially available in the United States, Europe, and South Korea, the
TwitchView™ neuromuscular TOF monitor uses electromyography (EMG) to provide clinicians with
reliable and accurate quantitative TOF data.

Justin Hulvershorn, MD, PhD, Blink's CEO said, “Neuromuscular blocking drugs are used in almost 50%
of surgeries. The literature show that, in the absence of quantitative monitoring, nearly 4 out of every 10
patients will wake up from these surgeries with significant residual paralysis, which delays recovery and
can lead to life-threatening complications. To help prevent these complications, quantitative
neuromuscular monitoring is rapidly becoming the standard of care when neuromuscular blocking agents
are administered. Hospitals need these new monitors to integrate into the EMR to achieve significant and
lasting changes in practice. Based on our recent installations and understanding of the market, we believe
that the TwitchView System can be readily integrated into the EMR at over 90% of US hospitals.”

Elise Hyman, Blink's VP of Clinical Operations added, "We are partnering with large institutions to
implement hospital-wide programs to improve their management of neuromuscular blockade. These
programs involve education, reliable quantitative monitoring provided by our TwitchView System, and
EMR connectivity to track progress and support quality initiatives. Our mission is to provide technology
that improves patient safety, and we are dedicated to working alongside clinicians and hospitals to
eliminate residual paralysis."

About Blink Device Company

Blink Device Company aims to identify areas in medicine that can greatly benefit from technological
innovation. Its first product is the TwitchView Quantitative Monitor for neuromuscular blockade. The
company is headquartered in Seattle, Washington and their products are made in the USA. To learn more,
visit www.blinkdc.com

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Blink Device Company
Karl Schmidt
206-708-6043
Contact via Email
www.blinkdc.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/786319

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use